Promino Expands U.S. NCAA Athlete Platform with Multi-Sport NIL Agreement with Every True Tiger
Promino expands its U.S. NCAA NIL platform with Every True Tiger, the third-party marketing arm of the Missouri Tigers, and select student-athletes across leading sports, including football, basketball, wrestling and others. The agreement follows Promino's recently announced VMI NIL partnership and marks another step in the Company's growth across U.S. Division I athletics. Promino continues building athlete-driven awareness behind flagship Promino NSF Ce
Food / Beverages, Sports, Health
2026-06-18 6:00 AM EDT | Promino Nutritional Sciences, Inc.
Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods
Vancouver, British Columbia--(Newsfile Corp. - June 18, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc., is preparing to begin harnessing predictive AI to further its e-commerce consumer and wholesale sales platform. The initiative is engineered to leverage readily available predictive consumer behavior models to optimize, monetize, and scale the brand'
Technology, Biotechnology, Health
2026-06-18 6:00 AM EDT | Restart Life Sciences Corp.
Altus Copper Applies for Partial Revocation of Failure-to-File Cease Trade Order, Announces Proposed Financing and Provides Further Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - Altus Copper Corp. (the "Company") announces that it has applied to the British Columbia Securities Commission (the "BCSC") and the Ontario Securities Commission (the "OSC") for a partial revocation order (the "Partial Revocation Order") of the failure-to-file cease trade order jointly issued by the BCSC and the OSC on December 5, 2023 (the "FFCTO"). The Company further announces a proposed fina
Food / Beverages, Healthcare and Hospitals, Health
2026-06-17 5:30 PM EDT | Altus Copper Corp.
Hemostemix' $1,000,000 Private Placement and Update
Calgary, Alberta--(Newsfile Corp. - June 17, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce that the Company is closing up to $1,000,000 of financing in tranches from the sale of Units at $0.05 each. Each Unit shall consist of one Common Share in the capital of the Company ("Common Share") and one half common share purchase warrant ("1/2 Warrant"), with each whole Warrant (2 x 1/2 Warrants) entitling the holder to acquire one Common Share at a price of $
Biotechnology, Pharmaceuticals, Health
2026-06-17 5:22 PM EDT | Hemostemix Inc.
Tersis and Pingkas Meet with Freeport and Provincial Officials to Explore Potential Project in Bataan, Philippines
Brookville, Florida--(Newsfile Corp. - June 17, 2026) - Representatives from Tersis Technologies (OTCID: TERS) and Pingkas Capital recently met with Authority of the Freeport Area of Bataan (AFAB) administrator Hussein Pangandaman, the Public Private Partnership Investment Center (PPPIC) and their respective teams to discuss potential opportunities for the development of a waste-to-energy project within Bataan, Philippines.
Agriculture, Energy, Alternative Energy, Health
2026-06-17 2:59 PM EDT | Tersis Technologies Inc.
Plaza Capital Invests in Spring Loaded to Accelerate Global Expansion of Innovative Orthopedic Bracing
Halifax, Nova Scotia--(Newsfile Corp. - June 17, 2026) - Spring Loaded Technology Inc., a Canadian medical technology company pioneering novel orthopedic bracing and mobility solutions, today announced a strategic investment from Plaza Capital to support the company's next phase of growth, including international expansion, research and development, and continued advancement of evidence-based mobility solutions. The investment follows Spring Loaded's successful management-led buyout com
2026-06-17 7:00 AM EDT | Spring Loaded Technology
WELL Health Announces Voting Results for Election of Directors
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that at its annual general and special meeting held June 16, 2026 (the "Meeting"), all of the nominees for election as directors of the Compa
Technology, Computer Software, Healthcare and Hospitals, Health
2026-06-17 7:00 AM EDT | WELL Health Technologies Corp.
Defence Therapeutics to Participate in Bio International Convention 2026 Next Week for Strategic Partnership Discussions
Montreal, Quebec--(Newsfile Corp. - June 17, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce its participation in the BIO International Convention 2026, taking place June 22-25 in San Diego, California. Defence's team will be available throughout the conference to meet with pharmaceutical and biotechnology companies, investors, an
Biotechnology, Pharmaceuticals, Health
2026-06-17 3:15 AM EDT | Defence Therapeutics Inc.
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2026 Conference Call
Ontario and Chicago, Illinois--(Newsfile Corp. - June 16, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Friday, June 26, 2026 to discuss Medexus's results for its fourth fiscal quarter and fiscal year ended March 31, 2026. Medexus expects to file its financial statements and MD&A after markets close on June 25, 2026. To participate in the call, please dial the following numbers:
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-16 5:30 PM EDT | Medexus Pharmaceuticals Inc.
Adia Med Improves Quality of Care with Advanced Ultrasound-Guided IV Training
Winter Park, Florida--(Newsfile Corp. - June 16, 2026) - Adia Med, the regenerative medicine and advanced IV therapy division of Adia Nutrition Inc. (OTCQB: ADIA), today announced a major step forward in patient care quality. Renowned physician Dr. Brian Browning, DO, Lead Physician at Adia Med, will personally train the company's Advanced Practice Registered Nurses (APRNs) and Registered Nurses (RNs) in ultrasound-guided intravenous (IV) insertions and administrations using the innovative Bu
Healthcare and Hospitals, Health
2026-06-16 10:55 AM EDT | Adia Med Inc.
TelyRx Announces Voting Results from Annual General Meeting of Shareholders
Clearwater, Florida--(Newsfile Corp. - June 15, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, announced today that each of the following nominees proposed to be elected at the Annual Meeting of Shareholders held on Monday, June 15, 2026 (the "Meeting"), has been elected. In addition, the other resolution put to vote at the Meeting was passed.
Healthcare and Hospitals, Health
2026-06-15 6:57 PM EDT | TelyRx
Functional Brands Inc. Receives Nasdaq Staff Delisting Determination
Lake Oswego, Oregon--(Newsfile Corp. - June 15, 2026) - Functional Brands Inc. (NASDAQ: MEHA) (the "Company"), a leading innovator in wellness and performance products, announced today that on June 9, 2026, it received a written notification (the "Staff Determination") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that Nasdaq has determined to delist the Company's common stock from The Nasdaq Capital Market. As previously disclosed, on D
Household / Consumer / Cosmetics, Health
2026-06-15 8:00 AM EDT | Functional Brands Inc.
Extendicare Announces June 2026 Dividend of C$0.0441 per Share
Markham, Ontario--(Newsfile Corp. - June 15, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.0441 per common share of the Company for the month of June 2026, which is payable on July 15, 2026 to shareholders of record at the close of business on June 30, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare i
Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-15 8:00 AM EDT | Extendicare Inc.
CBIH Announces Patent-Related Scientific Framework for PTSD-Focused Cannabinoid and Psilocybin Research
Houston, Texas--(Newsfile Corp. - June 15, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading under the ticker symbol CBIH, today announced a new chapter in its PTSD-focused research journey, marked by the completion of its patent-related work and the continued exploration of the scientific relationship between cannabinoids and psilocybin in relation to trauma, memory, emotional regulation, and recovery. PTSD affects veterans, first responde
Biotechnology, Pharmaceuticals, Cannabis, Health
2026-06-15 7:00 AM EDT | Cannabis Bioscience International Holdings
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Northvale, New Jersey--(Newsfile Corp. - June 15, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche generic products, today reported positive results from a pivotal bioequivalence study for an undisclosed anticonvulsant generic drug product. IQVIA reported branded and generic product sales for the twelve months ending April 2026 of $840 million.
Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-15 7:00 AM EDT | Elite Pharmaceuticals, Inc.
Cosmo Welcomes the Launches of Winlevi(R) in Austria and Germany
Ireland and Heppenheim, Germany--(Newsfile Corp. - June 15, 2026) - Cosmo N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) is pleased to announce the launch of its innovative acne cream Winlevi® (clascoterone 1% cream) in Austria and Germany by its commercial partner InfectoPharm Arzneimittel und Consilium GmbH (“InfectoPharm”). Winlevi® is available in both countries since June 1. Cosmo is the exclusive manufacturer of the product.
Healthcare and Hospitals, Health
2026-06-15 1:01 AM EDT | Cosmo Pharmaceuticals N.V.
PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - June 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated May 12, 2026 and April 22, 2026, it has closed a second tranche (the "Second Tranche") of its previously announced non-brokered private placement (the "Offering"), which Second Tranche consisted of the issuance of 9,800,000 units
Biotechnology, Pharmaceuticals, Health
2026-06-12 5:39 PM EDT | PreveCeutical Medical Inc.
Senior Care Authority Releases Father's Day Guide with 10 Warning Signs that Aging Parents Need Support
Incline Village, Nevada--(Newsfile Corp. - June 12, 2026) - Senior Care Authority shares insights on Father’s Day visits, highlighting how the occasion can help families notice when aging parents may be struggling in ways not visible from a distance. "Holiday visits are often when families first notice something has changed," said Frank Samson, founder and CEO of Senior Care Authority. "It's not always dramatic. Sometimes it's a messy kitchen or a conversation that feels sli
Healthcare and Hospitals, Health
2026-06-12 9:00 AM EDT | Senior Care Authority
Akanda Corp. Regains Compliance with Nasdaq Periodic Filing Requirement
Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that on June 10, 2026, it received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the "SEC")
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-06-12 8:00 AM EDT | Akanda Corp
Neural Therapeutics Announces AGSM Results, CFO Appointment and Welcomes Positive Developments in the German Cannabis Market
Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") is pleased to announce the results of its annual general and special meeting of shareholders held on May 25, 2026 (the "Meeting"), including shareholder approval of the acquisition by Neural of the remaining 69.25% equity interest in CWE European Holdings Inc. ("CWE") not already owned by the Company, through a series of ancillary transa
Biotechnology, Pharmaceuticals, Health, Psychedelics
2026-06-12 7:30 AM EDT | Neural Therapeutics Inc.